Market closed

vTv Therapeutics/$VTVT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About vTv Therapeutics

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.

Ticker

$VTVT
Trading on

Industry

Biotechnology

Employees

23

vTv Therapeutics Metrics

BasicAdvanced
$54M
-
-$3.20
0.81
-
$54M
0.81
$29.09
$12.12
13K
7.335
7.1
1.182
-61.33%
1,068.97%
116.386
4.39
4.39
-4.677
-67.06%
-36.68%
-27.20%

What the Analysts think about vTv Therapeutics

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for vTv Therapeutics stock.

vTv Therapeutics Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

vTv Therapeutics Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $VTVT

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for vTv Therapeutics stock?

vTv Therapeutics (VTVT) has a market cap of $54M as of May 03, 2025.

What is the P/E ratio for vTv Therapeutics stock?

The price to earnings (P/E) ratio for vTv Therapeutics (VTVT) stock is 0 as of May 03, 2025.

Does vTv Therapeutics stock pay dividends?

No, vTv Therapeutics (VTVT) stock does not pay dividends to its shareholders as of May 03, 2025.

When is the next vTv Therapeutics dividend payment date?

vTv Therapeutics (VTVT) stock does not pay dividends to its shareholders.

What is the beta indicator for vTv Therapeutics?

vTv Therapeutics (VTVT) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.